TrialPanorama/TrialPanorama-database huggingface dataset:
Study 31138727 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 31753429 — Predictive Biomarker (PRD); Safety Biomarker (SAF): STAR mRNA
Genes: STAR; STARD1
Study 23232827 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 9744493 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16749414 — Surrogate Endpoint (SUR): Blood pressure
Study 9783333 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 17958029 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 17958029 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 15266329 — Predictive Biomarker (PRD): Hormone receptor
Study 15266329 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15266329 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 27720142 — Surrogate Endpoint (SUR): Blood pressure
Study 1487552 — Surrogate Endpoint (SUR): Blood pressure
Study 1487552 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 1487552 — Surrogate Endpoint (SUR): Serum sodium
Study 25218903 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 31302276 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 14517597 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study 14517597 — Surrogate Endpoint (SUR): Bone mineral density
Study 30096139 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 20207521 — Surrogate Endpoint (SUR): Blood pressure
Study 10339777 — Surrogate Endpoint (SUR): Bone mineral density
Study 1709185 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 1709185 — Predictive Biomarker (PRD): RNASE2 mRNA
Genes: RNASE2; EDN; RNS2
Study 17350969 — Surrogate Endpoint (SUR): Blood pressure
Study 10302355 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 28127204 — Monitoring Biomarker (MOI): HBV DNA
Study 9686498 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 12874608 — Surrogate Endpoint (SUR): Blood pressure
Study 8560674 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 30617197 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 30617197 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 30239561 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 11880561 — Surrogate Endpoint (SUR): Blood pressure
Study 10193912 — Surrogate Endpoint (SUR): Blood pressure
Study 8566890 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 31190609 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31190609 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 16772904 — Predictive Biomarker (PRD): TICAM2 mRNA
Genes: TICAM2; TIRAP3; TIRP; TRAM
Study 11232016 — Surrogate Endpoint (SUR): Serum testosterone
Study 11232016 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 11232016 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8430630 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 29406607 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21372246 — Predictive Biomarker (PRD): TES mRNA
Genes: TES
Study 18309452 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 8938284 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 8938284 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 29452031 — Surrogate Endpoint (SUR): Blood pressure
Study 23934773 — Predictive Biomarker (PRD): PDIA3 mRNA
Genes: PDIA3; ERP57; ERP60; GRP58
Study 23934773 — Safety Biomarker (SAF): Glutathione S-transferase P
Genes: GSTP1; FAEES3; GST3
Study 8952582 — Surrogate Endpoint (SUR): Blood pressure
Study 11673815 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25450847 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25450847 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 1677820 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 28070882 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 17402468 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 7931040 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 7931040 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31662030 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 9082675 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 25894405 — Predictive Biomarker (PRD): SOCS3 mRNA
Genes: SOCS3; CIS3; SSI3
Study 25894405 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 17206669 — Safety Biomarker (SAF): Bacteroidetes phylum
Study 28467859 — Surrogate Endpoint (SUR): Blood pressure
Study 8857441 — Surrogate Endpoint (SUR): Blood pressure
Study 6305546 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 6305546 — Surrogate Endpoint (SUR): Blood pressure
Study 31432311 — Surrogate Endpoint (SUR): Probing pocket depth
Study 27006286 — Surrogate Endpoint (SUR): Blood pressure
Study 24927970 — Surrogate Endpoint (SUR): Serum creatinine
Study 24927970 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 8094279 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 18566593 — Predictive Biomarker (PRD): PIP mRNA
Genes: PIP; GCDFP15; GPIP4
Study 16336334 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 16336334 — Surrogate Endpoint (SUR): Serum sodium
Study 7496696 — Surrogate Endpoint (SUR): Blood pressure
Study 31412895 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29562156 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 29562156 — Predictive Biomarker (PRD): Chromosome 17p
Study 12365197 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 7406204 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study 26187233 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23573255 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 16440148 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 16440148 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 16440148 — Safety Biomarker (SAF): Reactive oxygen species
Study 10891820 — Surrogate Endpoint (SUR): Bone mineral density
Study 8979288 — Surrogate Endpoint (SUR): Urine free cortisol
Study 3519883 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study 28381428 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 20226502 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 19213341 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19213341 — Safety Biomarker (SAF): Urinary total protein
Study 1457271 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 1457271 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 30446494 — Predictive Biomarker (PRD): FANCL mRNA
Genes: FANCL; PHF9
Study 30446494 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study 30446494 — Predictive Biomarker (PRD): CREBBP mRNA
Genes: CREBBP; CBP
Study 30446494 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 16125499 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 11831838 — Surrogate Endpoint (SUR): Blood pressure
Study 7494939 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29587875 — Surrogate Endpoint (SUR): Blood pressure
Study 22647889 — Surrogate Endpoint (SUR): Blood pressure
Study 18344886 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 30526678 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28356129 — Surrogate Endpoint (SUR): Blood pressure
Study 23650505 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 22417251 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 12859160 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 24637941 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 24637941 — Surrogate Endpoint (SUR): Blood pressure
Study 24637941 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 8624887 — Surrogate Endpoint (SUR): Blood pressure
Study 16996597 — Surrogate Endpoint (SUR): Blood pressure
Study 3553480 — Surrogate Endpoint (SUR): Blood pressure
Study 22939758 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study 16801459 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 30175844 — Predictive Biomarker (PRD): RASA4 mRNA
Genes: RASA4; CAPRI; GAPL; KIAA0538
Study 30175844 — Predictive Biomarker (PRD): DHFR mRNA
Genes: DHFR
Study 30175844 — Predictive Biomarker (PRD): DHFR2 mRNA
Genes: DHFR2; DHFRL1; DHFRP4
Study 17885011 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 17885011 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 17885011 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17885011 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 17885011 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 28231822 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 27128214 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 11452245 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 23418877 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 21080183 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 15291994 — Surrogate Endpoint (SUR): Blood pressure
Study 9626923 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 7909822 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 3586502 — Surrogate Endpoint (SUR): Blood pressure
Study 18534636 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 8350327 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 29398672 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 20861424 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 20861424 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 9261912 — Surrogate Endpoint (SUR): Blood pressure
Study 8415813 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 24115138 — Surrogate Endpoint (SUR): Bone mineral density
Study 6362905 — Surrogate Endpoint (SUR): Blood pressure
Study 26852904 — Predictive Biomarker (PRD): FFAR2 mRNA
Genes: FFAR2; FFA2; GPCR43; GPR43
Study 26852904 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 20414532 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 8955968 — Surrogate Endpoint (SUR): Blood pressure
Study 29151409 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 29151409 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29151409 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29151409 — Surrogate Endpoint (SUR): Serum creatinine
Study 29151409 — Safety Biomarker (SAF): IL-6 and IL-10
Study 16429411 — Predictive Biomarker (PRD): GDNF mRNA
Genes: GDNF
Study 7955745 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 3296971 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 26658227 — Safety Biomarker (SAF): Dihydrothymine dehydrogenase
Genes: DPYD
Study 26942445 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 24481874 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 14977792 — Surrogate Endpoint (SUR): Blood pressure
Study 8163325 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 3280363 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 10515238 — Predictive Biomarker (PRD): IL2
Genes: IL-2; TCGF
Study 10515238 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 10515238 — Safety Biomarker (SAF): Interleukin 12
Study 10515238 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 10515238 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 1902997 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 19675867 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 15148925 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 9690949 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 7866002 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 18060379 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18060379 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 27493757 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 24213952 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 24213952 — Predictive Biomarker (PRD): ASRGL1 mRNA
Genes: ASRGL1; ALP; CRASH
Study 17320568 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 17320568 — Surrogate Endpoint (SUR): Serum sodium
Study 23615499 — Surrogate Endpoint (SUR): Serum creatinine
Study 18400708 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 20392360 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 16425357 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9021810 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 17381494 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 2370647 — Surrogate Endpoint (SUR): Blood pressure
Study 18477935 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 18477935 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18477935 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 18477935 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 18477935 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 10620552 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24090821 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 16682719 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 16682719 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 9013375 — Surrogate Endpoint (SUR): Blood pressure
Study 1349294 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 29718092 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 29718092 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 29718092 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 29718092 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 29718092 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study 29718092 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study 29718092 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 29718092 — Predictive Biomarker (PRD): Hormone receptor
Study 11856098 — Surrogate Endpoint (SUR): Serum sodium
Study 21259004 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21259004 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 19458017 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28666095 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 28666095 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study 28666095 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 28666095 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19882171 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 11144863 — Surrogate Endpoint (SUR): Plasma ammonia
Study 29661477 — Surrogate Endpoint (SUR): Blood pressure
Study 27431451 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 27431451 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 24343119 — Surrogate Endpoint (SUR): Blood pressure
Study 21127697 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21127697 — Surrogate Endpoint (SUR): Blood pressure
Study 16014059 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 16014059 — Surrogate Endpoint (SUR): Blood pressure
Study 16014059 — Surrogate Endpoint (SUR): Serum creatinine
Study 16014059 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 9419196 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 791329 — Surrogate Endpoint (SUR): Blood pressure
Study 2080949 — Surrogate Endpoint (SUR): Serum calcium
Study 31226123 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25648211 — Surrogate Endpoint (SUR): Blood pressure
Study 19679843 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 29917338 — Monitoring Biomarker (MOI): Procalcitonin
Study 29917338 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29917338 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 29917338 — Surrogate Endpoint (SUR): Serum creatinine
Study 2446058 — Surrogate Endpoint (SUR): Blood pressure
Study 27865174 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 27865174 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 27865174 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 20728065 — Predictive Biomarker (PRD): APRT mRNA
Genes: APRT
Study 15963092 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 10470389 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 9211625 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 9211625 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 2718782 — Surrogate Endpoint (SUR): Serum calcium
Study 25817614 — Surrogate Endpoint (SUR): Blood pressure
Study 21375762 — Surrogate Endpoint (SUR): Blood pressure
Study 19713967 — Surrogate Endpoint (SUR): Blood pressure
Study 17597089 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 17597089 — Predictive Biomarker (PRD): PF4 mRNA
Genes: PF4; CXCL4; SCYB4
Study 8002117 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 8002117 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 2527244 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study 2527244 — Surrogate Endpoint (SUR): Blood pressure
Study 30674610 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10491213 — Safety Biomarker (SAF): Biliary glycoprotein 1
Genes: CEACAM1; BGP; BGP1
Study 1725539 — Surrogate Endpoint (SUR): Blood pressure
Study 1725539 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 31567875 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 23727057 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 19222929 — Predictive Biomarker (PRD): NTS mRNA
Genes: NTS
Study 26930607 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 20954664 — Safety Biomarker (SAF): Hyaluronic acid
Study 7474676 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 7474676 — Surrogate Endpoint (SUR): Blood pressure
Study 44770 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 44770 — Surrogate Endpoint (SUR): Blood pressure
Study 15366789 — Predictive Biomarker (PRD): TFPI mRNA
Genes: TFPI; LACI; TFPI1
Study 15366789 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 15366789 — Surrogate Endpoint (SUR): Blood pressure
Study 24122840 — Predictive Biomarker (PRD): PROX1 mRNA
Genes: PROX1
Study 18194383 — Predictive Biomarker (PRD): SNAP25 mRNA
Genes: SNAP25; SNAP
Study 8787257 — Surrogate Endpoint (SUR): Blood pressure
Study 7282308 — Surrogate Endpoint (SUR): Blood pressure
Study 7282308 — Surrogate Endpoint (SUR): Serum triglycerides
Study 27680969 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24813374 — Predictive Biomarker (PRD): SLC6A3 mRNA
Genes: SLC6A3; DAT1
Study 24813374 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 19195328 — Monitoring Biomarker (MOI): HBV DNA
Study 15787659 — Predictive Biomarker (PRD): NPL mRNA
Genes: NPL; C1orf13
Study 31835476 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 29856685 — Predictive Biomarker (PRD): MYD88 mRNA
Genes: MYD88
Study 29856685 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 26163858 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study 24170391 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 19074911 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19074911 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17867511 — Predictive Biomarker (PRD): CPD mRNA
Genes: CPD
Study 21819934 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 9012545 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4